Pharmaceutical Services Federal Committee of Inquiry
Provisions for the Pharmaceutical Services Committee of Inquiry have been included within the National Health Act for some time. The Act allows that the Committee can be established at either a state or federal level. State level committees were last active approximately 20 years ago. A growing number of complaints regarding the conduct of approved pharmacists in relation to the supply and claiming of Pharmaceutical Benefits Scheme medicines from premises for which the pharmacists were not approved prompted the previous Minister for Health to direct the Department to re-establish the Committee. This will allow the committee to investigate matters, at a federal level, of non-compliance with conditions of approval for approved pharmacists. It is for this reason the Pharmaceutical Services Federal Committee of Inquiry has been established. The National Health Act specifies the membership of the committee to consist of four pharmacists to be appointed by the Minister for Health as well as the Secretary (or their delegate who must be a Departmental officer who is a medical practitioner or pharmacist).
Type of Body
E. Statutory Office Holder Offices and Committees
Established By / Under
Act / Regulation
Established By/Under More info
National Health Act 1953
Max No. of Board/Committee Members
Annual Report Prepared and tabled?
Regulatory / Review / Inquiry / Commission
20 April 2015